IndraLab
Statements
Hydroxychloroquine inhibits inflammatory response. 68 / 68
|
9
59
eidos
"Mode of action of CQ / HCQ CQ / HCQ has multiple mode of mechanisms that may be useful in treatment of SARS-CoV-2 [ 45,63 ] : a b c d e HCQ not only attenuate the inflammatory response but also decrease the level of cytokines which is generally higher in patients infected with SARS-CoV-2 ."
| PMC
reach
"Therefore, if this unique immune quiescent state can be pharmacologically induced locally, it will provide an excellent women oriented strategy against HIV infection To our knowledge, this is the first research article evaluating in vivo, an innovative trackable implant that can provide controlled delivery of hydroxychloroquine (HCQ) to successfully attenuate vaginal T lymphocyte activation and inflammation in a rabbit model as a potential strategy to induce an " immune quiescent " state within the FGT for the prevention of HIV infection."
reach
"Two potential pathways were inferred to be involved in the protective effect of hydroxychloroquine in CAD : (a) hydroxychloroquine may activate ERK5 (encoded by MAPK7) to prevent endothelial inflammation via inhibition of cell adhesion molecule expression 24; and (b) hydroxychloroquine may inhibit endosomal activation of NADPH oxidase in response to pro inflammatory agonists (TNF-alpha and IL-1beta) and may decrease production of pro inflammatory cytokines in stimulated immune cells 25."
reach
"Hydroxychloroquine can reduce the inflammatory response and cytokine storm (aggressive inflammatory response with the release of a large amount of pro inflammatory cytokines) in patients severely infected with SARS-CoV-2 by blocking T-cell stimulation, and thus decreasing cytokine production."
| PMC
reach
"Hydroxychloroquine has also been reported to reduce the inflammatory response and cytokine storm in vitro, to reduce proinflammatory cytokine production, to activate anti-SARS-CoV-2 T cells, to inhibit virus-cell junction by increasing endosomal pH, and to inhibit pH-dependent steps of viral replication.2 3 Due to these mechanisms of action, it has been used in the treatment of COVID-19 during the pandemic process."
reach
"Recommendations on the use of HCQ are based on current clinical practices as literature is scarce and limited to some cases for cutaneous (7–10) and musculoskeletal involvement (11–13) Although the underlying mechanism in sarcoidosis is still largely unknown, it is suggested that HCQ suppresses inflammation (6,12) with potentially fewer side effects (14)."
reach
"Therefore, it is reasonable to believe that HCQ may reduce renal inflammation in IgAN patients by inhibiting TLR signaling in mucosal and renal tissues, modulating immune responses, increasing intracellular pH, stimulating nitric oxide synthesis, and reducing the production of Gd-IgA1."
reach
"In addition, immunomodulatory or immunosuppressive treatments, such as anti-IL-6, anti-IL-6R, anti-IL-1beta, chloroquine and hydroxychloroquine inhibit the host inflammatory response by neutralizing the role of cytokines or their cognate receptors to further reduce immune response triggered by the virus."
reach
"Besides, in silico platforms have suggested that diflunisal, nabumetone, niflumic acid, and valdecoxib may be suitable for the treatment of T1DM; phenoxybenzamine and idazoxan for the treatment of T2DM by improving insulin secretion; and hydroxychloroquine reduce the risk of coronary heart disease (CHD) by counteracting inflammation."
eidos
"( 30,31 ) Hydroxychloroquine is commonly used in rheumatologic disorders for its immunomodulatory effects , ( 32 ) and also mitigates inflammation by increasing the pH of intracellular vacuoles to disrupt antigen binding , disrupting calcium dependent intracellular signaling , ( 33 ) decreasing macrophage mediated cytokine production , ( 34 ) and inhibiting toll like receptor signaling ."